Paul Chaplin

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
BAVARIAN NORDIC A/S
8
6
5
6
3
6
3
15
5
3
4
3
1
2003
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2016
2017
BAVARIAN NORDIC A/S C/O BAVARIAN NORDIC, INC.
2
2012

Inventor Addresses

AddressDuration
GRAFELFING, DENov 01, 12 - Dec 27, 12
Gafelfing, DEFeb 04, 16 - Jul 18, 17
Gräfelfing, DEAug 19, 14 - Feb 23, 16
Grafelfing, DEMay 31, 12 - Nov 16, 17
München, DEMar 10, 09 - Dec 04, 12
MUNCHEN, DEJul 22, 10 - Dec 15, 11
MUNICH, DESep 08, 11 - Sep 08, 11
Mucnchen, DEFeb 25, 10 - Feb 25, 10
Munchen, DEOct 30, 03 - May 03, 12
Munich, DEJul 13, 04 - Feb 12, 13
US -

Technology Profile

Technology Matters
A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 6
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 41
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 17

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2017/0326,2282017RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE0
97177872017Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine0
97072912017Single high dose of MVA induces a protective immune response in neonates and infants0
2017/0081,6422017RECOMBINANT POXVIRUS VECTOR COMPRISING TETANUS TOXIN FRAGMENT C0
2017/0043,0082017RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.